- REPL Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
8-K Filing Data
Replimune (REPL) 8-K22 Jan 25Replimune Announces Biologics License Application Acceptance and Priority Review for RP1 for the Treatment of Advanced MelanomaFinancial data
Company Profile